Cargando…
Mesenchymal stem cell-derived exosomes for gastrointestinal cancer
Gastrointestinal (GI) malignancies, a series of malignant conditions originating from the digestive system, include gastric cancer, hepatocellular carcinoma, pancreatic cancer, and colorectal cancer. GI cancers have been regarded as the leading cancer-related cause of death in recent years. Therefor...
Autores principales: | Zhao, Lin-Xian, Zhang, Kai, Shen, Bing-Bing, Li, Jian-Nan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8713327/ https://www.ncbi.nlm.nih.gov/pubmed/35070036 http://dx.doi.org/10.4251/wjgo.v13.i12.1981 |
Ejemplares similares
-
Emerging roles of mesenchymal stem cell-derived exosomes in gastrointestinal cancers
por: Wang, Naijian, et al.
Publicado: (2022) -
Mesenchymal stem cells-derived exosomes for drug delivery
por: Sun, Yao, et al.
Publicado: (2021) -
Exosomes Derived from Mesenchymal Stem Cells
por: Yu, Bo, et al.
Publicado: (2014) -
Efficacy of mesenchymal stem cells in the treatment of gastrointestinal malignancies
por: Li, Jian-Nan, et al.
Publicado: (2020) -
Mechanisms and therapeutic prospects of mesenchymal stem cells-derived exosomes for tendinopathy
por: Zhang, Yuxiang, et al.
Publicado: (2023)